Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Increasing cell culture applications in research and product development is an important factor driving growth of the global cell culture monitoring biosensor market. Application of cell culture is quite significant and pronounced in every research and product development in the food, pharmaceutical, biotechnology, and other sectors. Cell culture technique has enabled quick manufacturing of vaccines and biotechnology products. Moreover, a spike in growth is expected in the biosimilars market, which will further propel demand for cell culture monitoring and hence, the need for biosensors. Personalized medicines is the new trend in the market. Cell culture technique is used for identifying potential biomarkers and developing a targeted drug therapy requires accurate and continuous monitoring of critical cell culture parameters at regular time interval. All these factors are expected to fuel demand for cell culture monitoring biosensors during the forecast period.
Global Cell Culture Monitoring Biosensor Market - Impact of Coronavirus (COVID-19) Pandemic
The spread of the novel coronavirus has hampered growth of the pharmaceutical industry. In December 2019, in China’s Wuhan City, a cluster of pneumonia cases were reported by Chinese health authorities. The pneumonia causative agent was identified as a novel coronavirus named COVID-19. This virus spread rapidly across the globe, thus causing a concerning number of fatalities. In March, 2020, the World Health Organization (WHO) declared the COVID-19 as a global pandemic and suggested implementation of strict measures to minimize the spread of this disease. The pandemic has slowed down growth of the healthcare sector and led to a disturbance in the supply chain.
Moreover, governments across various countries have implemented nationwide lockdowns to curb the spread of COVID-19. Similarly, in various countries across the world, healthcare companies are facing problems of continuing its supply chain operations. The slowdown of the healthcare companies’ supply chain has also impacted growth of the global cell culture monitoring biosensor market.
The global cell culture monitoring biosensor market is estimated to be valued at US$ 332.0 million in 2020 and is expected to exhibit a CAGR of 9.6% during the forecast period (2020-2027).
Figure 1. Global Cell Culture Monitoring Biosensor Market Share (%) Analysis, By Product Type, 2020
Global Cell Culture Monitoring Biosensor Market - Restraints
The global cell culture monitoring biosensor market growth is expected to be hampered by automated cell culture monitoring phasing into the cell culture monitoring market, suppliers of devices need to ensure accuracy and security of data generated. The lack of accuracy and sensitivity of biosensors cost very high to the companies producing cell culture. This concern of companies is expected to be a major restraining factor for the adoption of cell culture monitoring biosensors.
Global Cell Culture Monitoring Biosensor Market: Opportunities
3D cell culture holds much promise in developing personalized treatment. This technique has further encouraged researchers to use new cell culture technologies to optimize their outcomes and improve efficiency. Cell culture monitoring biosensors would find an opportunity with rising awareness and adoption of automated cell culture monitoring devices to improve efficiency and optimize outcomes.
Cell Culture Monitoring Biosensor Market Report Coverage
||Market Size in 2019:
||US$ 332.0 Mn
|Historical Data for:
||2017 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 632.0 Mn
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
- By Product Type: Electrochemical Biosensors, Thermometric Biosensors, Fiber Optic Biosensors, Pizoelectric Biosensors, Others.
- By End User: Pharmaceutical Industry, Biotechnology Organizations, Research Laboratories.
C-CIT Sensors AG, Sarissa Biomedical Ltd, Lonza, Lifeonics ltd., Nova Biomedical, Cardea, Conductive Technologies Inc., and Bruker Corporation
- Increasing cell culture application in research and product development
|Restraints & Challenges:
- Concern of sensitivity and accuracy of cell culture monitoring biosensor
Global Cell Culture Monitoring Biosensor Market – Regional Analysis
On the basis of region, the global cell culture monitoring biosensor market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to witness significant growth in the global cell culture monitoring biosensor market, owing to launch of new products in the market. For instance, in March 2019, Lonza launched Custom Cell Biology Services for pharmaceutical companies and contract manufacturing organizations. The services include cell-line expansion and banking, media production, cell isolation, cell characterization, transfection services, and 3-dimensional (3D) cell-culture services.
Asia Pacific is expected to witness significant growth during the forecast period, as key players are focused on adopting strategies such as distribution partnerships, which is expected to drive growth of the cell culture monitoring biosensor market in this region. For instance, in 2018, Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) announced a long-term collaboration to advance basic and translational research in reproductive medicine through the development of novel product candidates and therapeutic strategies.
Europe is also expected to witness potential growth in the global cell culture monitoring biosensor market, owing to increasing product launches by the key players in the market. For instance, in August 2018, C-CIT Sensors launched CITSens MeMo, an electrochemical, enzyme-based and single-use sensor, which helps in continuous online/real-time measurement of glucose and lactate in cell cultures.
Figure 2. Global Cell Culture Monitoring Biosensor Market Value (US$ mn) & Y-o-Y Growth (%), 2017-2027
Global Cell Culture Monitoring Biosensor Market - Competitive Landscape
Key players operating in the global cell culture monitoring biosensor market include C-CIT Sensors AG, Sarissa Biomedical Ltd, Lonza, Lifeonics ltd., Nova Biomedical, Cardea, Conductive Technologies Inc., and Bruker Corporation.